Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Brain Gadolinium Deposition Between Linear and Macrocyclic GBCAs in Liver Cancer Patients
ChiCTR2000039419Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2020
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of gadoteridol and gadopentetate dimeglumine in liver cancer (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: T1 signal of basal ganglia and Adverse events. Started Oct 2020; status: recruiting.
02
Drugs
gadoteridolgadopentetate dimeglumine
03
Conditions
liver cancer
Beyond the preview
Go deeper on ChiCTR2000039419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039419.